Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
interleukin 8 | 1 | 0 | 0 | 1 |
pregnane X receptor | 1 | 0 | 0 | 1 |
RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
ATAD5 protein, partial | 2 | 0 | 0 | 2 |
TDP1 protein | 3 | 0 | 0 | 3 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
AR protein | 4 | 0 | 0 | 4 |
aldehyde dehydrogenase 1 family, member A1 | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 3 | 0 | 0 | 3 |
progesterone receptor | 2 | 0 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 4 | 0 | 0 | 4 |
retinoic acid nuclear receptor alpha variant 1 | 3 | 0 | 0 | 3 |
retinoid X nuclear receptor alpha | 2 | 0 | 0 | 2 |
estrogen-related nuclear receptor alpha | 4 | 0 | 0 | 4 |
pregnane X nuclear receptor | 3 | 0 | 0 | 3 |
estrogen nuclear receptor alpha | 4 | 0 | 0 | 4 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
arylsulfatase A | 2 | 0 | 0 | 2 |
IDH1 | 2 | 0 | 0 | 2 |
euchromatic histone-lysine N-methyltransferase 2 | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
Nuclear hormone receptor family member daf-12 | 0 | 0 | 1 | 1 |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 3 | 0 | 0 | 3 |
serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
oxysterols receptor LXR-beta isoform 1 | 0 | 0 | 1 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
geminin | 3 | 0 | 0 | 3 |
peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
Thymidine kinase, cytosolic | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 2 | 0 | 0 | 2 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Spike glycoprotein | 3 | 0 | 0 | 3 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Ataxin-2 | 2 | 0 | 0 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
glp-1 receptor, partial | 2 | 0 | 0 | 2 |
thioredoxin reductase | 2 | 0 | 0 | 2 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
GLI family zinc finger 3 | 3 | 0 | 0 | 3 |
Thrombopoietin | 1 | 0 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 1 | 0 | 0 | 1 |
EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
farnesoid X nuclear receptor | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
polyprotein | 1 | 0 | 0 | 1 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
caspase-3 | 1 | 0 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 1 | 0 | 0 | 1 |
transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
Cocaine esterase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 4 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Major prion protein | 0 | 0 | 1 | 1 |
Vitamin D-binding protein | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Cytochrome P450 3A4 | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 1 | 5 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 1 | 0 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 1 | 0 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
D | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 1 | 0 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 0 | 2 | 0 | 3 |
D(4) dopamine receptor | 0 | 2 | 1 | 5 |
D(1B) dopamine receptor | 0 | 2 | 0 | 3 |
Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 1 | 0 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 1 | 0 | 0 | 1 |
D(4) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
C-8 sterol isomerase | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 2 | 1 | 5 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 1 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 1 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 1 | 0 | 0 | 1 |
N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Zinc finger protein 664 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
Transporter | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Protease | 0 | 2 | 0 | 2 |
Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
GABA theta subunit | 1 | 0 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 1 |
D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 1 | 0 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
Luciferase | 2 | 0 | 0 | 2 |
estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 1 | 0 | 0 | 1 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 2 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
GALC protein | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 1 | 0 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
Vpr | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Cellular tumor antigen p53 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |